Claire Dagorno

Claire Dagorno

Auto-generated profile, based on publicly available information

Claire Dagorno

Department of Pediatric Surgery, Urology and Transplantation, Necker-Enfants Malades Hospital, APHP, Paris, France.

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
CDClaire Dagorno
Claire Dagorno
LMLouise Montalva
Louise Montalva
LALiza Ali
Liza Ali
RBRaffaele Brustia
Raffaele Brustia
APAnnabel Paye-Jaquen
Annabel Paye-Jaquen
ABArnaud Bonnard
Arnaud Bonnard

26 September 2024 in Journal of Pediatric Surgery
Verified
Journal Article
Open access
CDClaire Dagorno
Claire Dagorno
LMLouise Montalva
Louise Montalva
CCCarmen Capito
Carmen Capito
FLFrederic Lavrand
Frederic Lavrand
AGAudrey Guinot
Audrey Guinot
ABArnaud Bonnard
Arnaud Bonnard
Short Bowel Syndrome (SBS), secondary to various underlying diseases, is one of the main causes of intestinal failure in children. Surgical management by serial transverse enteroplasty (STEP), is feasible in selected cases, but results on long-term follow-up are scarce. The aim of this study was to report long-term outcomes of the STEP procedure in children with SBS. We performed a multicenter national retrospective study reviewing medical charts of children who underwent a STEP technique between 2000 and 2022 in 6 university hospitals. Collected data included demographics, SBS history, surgical procedures, nutritional support (enteral or parenteral), STEP management, complications, and outcomes (nutritional support, digestive symptoms, growth). STEP was performed in 36 SBS, resulting from 14 gastroschisis, 10 intestinal atresia, 8 necrotizing enterocolitis (NEC), 2 midgut volvulus, and 2 intestinal Hirschsprung disease. Median age at first STEP was 10.8 months [4.5; 63.8]. Bowel length significantly increased (47 vs 70 cm, p < 0.01), with a median gain of 16 cm [11; 25] or 34%. At surgery, 33 children had parenteral nutrition (PN). A second STEP was performed in 11 patients, at a median age of 4.2 years [2.8; 6.8]. One patient underwent a third STEP. Two children required intestinal transplantation. Median follow-up was 7 years [4.4;11.4]. Out of 33 children requiring PN before surgery, 14 children were weaned off PN. The remaining 19 children still required PN, but their dependency decreased by 19%. Out of 17 children presenting severe intestinal dilations and bacterial overgrowth, 12 became asymptomatic. Out of 20 with chronic obstructive symptoms, 8 patients still required supplementary PN whereas 12 achieved complete enteral autonomy, including 3 requiring supplementary enteral support. STEP technique remains a surgical option in the management of these children, enabling a decrease in PN dependency, resulting in weaning off PN in some cases, as well as an improvement of clinical symptoms. Retrospective multicenter observational study. Level 3.

30 January 2026 in European Journal of Pediatric Surgery
Verified
Journal Article
Closed access
CDClaire Dagorno
Claire Dagorno
MKMaxime Koffi
Maxime Koffi
LGLouise Galmiche
Louise Galmiche
YAYves Aigrain
Yves Aigrain
CMCecile S. Martin
Cecile S. Martin
CCCarmen Capito
Carmen Capito
Focal forms of congenital hyperinsulinism (FoCHI) are rare pediatric conditions managed using established metabolic and surgical protocols. To date, the use of a robotic approach for this surgery in children has not been described. We present our initial experience with robotic pancreatectomy, compared with the open approach, for the management of FoCHI. We conducted a retrospective, single-center study involving 25 children who underwent pancreatectomy for CHI between 2011 and 2024. Collected data included patient demographics, surgical details, complications, and post-operative outcomes. The Da Vinci Xi robotic system was used for all robotic procedures. Ten patients underwent robotic pancreatectomy, and 10 underwent open surgery; five children treated laparoscopically were excluded. There were no significant differences between the robotic and open groups in median weight at surgery (7.7 kg vs. 7.3 kg, p = 0.7), median age (7 months vs. 5.9 months, p = 0.48), median operative time (298 minutes vs. 285 minutes, p = 0.5), length of stay (14 days vs. 14.5 days, p = 0.26), or time to postoperative feeding resumption (4 days vs. 4.5 days, p = 0.68). Intraoperatively, 80% of lesions were visible on the pancreatic surface. Two cases of incomplete resection occurred in each group; after multidisciplinary review, both patients in the robotic group required a second procedure. No intraoperative bleeding or conversions were reported. The overall cure rate was 90% in the robotic group and 80% in the open surgery group. This preliminary study suggests that robotic pancreatectomy for congenital hyperinsulinism may be both safe and feasible. The robotic approach provides enhanced visualization of small vessels, enabling limited dissection and safe resection. Given the sample size, further studies are required to confirm these findings.

14 June 2026 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
CDClaire Dagorno
Claire Dagorno
DODaniel Orbach
Daniel Orbach
JGJulien Grosman
Julien Grosman
APAurore Pire
Aurore Pire
ADAnne Dariel
Anne Dariel
SSSabine Sarnacki
Sabine Sarnacki